Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells

被引:0
|
作者
Cobbs, CS
Whisenhunt, TR
Wesemann, DR
Harkins, LE
Van Meir, EG
Samanta, M
机构
[1] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA
[2] Vet Affairs Med Ctr, Surg Serv, Birmingham, AL USA
[3] Univ Alabama, Med Scientist Training Program, Birmingham, AL USA
[4] Emory Univ, Sch Med, Mol Neurooncol Lab, Atlanta, GA USA
[5] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are the most common primary brain tumors in adults, and the most malignant form, glioblastoma multiforme (GBM), is usually rapidly fatal. Most GBMs do not have p53 mutations, although the p53 tumor suppressor pathway appears to be inactivated. GBMs grow in a hypoxic and inflammatory microenviromnent, and increased levels of the free radicals nitric oxide (NO) and superoxide (O-2 radical anion,) occur in these malignancies in vivo. Peroxynitrite (ONOO-) is a highly reactive molecule produced by excess NO and W. that can posttranslationally modify and inactivate proteins, especially zinc finger transcription factors such as p53. We demonstrated previously that GBMs have evidence of tyrosine nitration, the "footprint" of per oxymtrite-mediated protein modification in vivo, and that peroxyrtitrite could inhibit the specific DNA binding ability of wild-type p53 protein in glioma cells in vitro. Here we show that both authentic peroxynitrite and SIN-1 (3-morpholinosydnonimine hydrochloride), a molecule that decomposes into NO and O-2 radical anion to form peroxynitrite, can inhibit wild-type p53 function in malignant glioma cells. Concentrations of peroxynitrite associated with a tumor inflammatory environment caused dysregulation. of wild-type p53 transcriptional activity and downstream p21(WAF1) expression.
引用
收藏
页码:8670 / 8673
页数:4
相关论文
共 50 条
  • [31] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614
  • [32] Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
    Trinidad, Antonio Garcia
    Muller, Patricia A. J.
    Cuellar, Jorge
    Klejnot, Marta
    Nobis, Max
    Maria Valpuesta, Jose
    Vousden, Karen H.
    MOLECULAR CELL, 2013, 50 (06) : 805 - 817
  • [33] ACCUMULATION OF WILD-TYPE P53 IN MENINGIOMAS
    ELLISON, DW
    LUNEC, J
    GALLAGHER, PJ
    STEART, PV
    JAROS, E
    GATTER, KC
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (02) : 136 - 142
  • [34] Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells
    Horiuchi, H
    Kawamata, H
    Omotehara, F
    Fujii, S
    Fujimori, T
    Kuroda, Y
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (08) : 801 - 803
  • [35] Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells
    Hideki Horiuchi
    Hitoshi Kawamata
    Fumie Omotehara
    Shigehiko Fujii
    Takahiro Fujimori
    Yoshikazu Kuroda
    Journal of Gastroenterology, 2004, 39 : 801 - 803
  • [36] REGULATION OF THE STRUCTURE AND FUNCTION OF WILD-TYPE AND MUTANT FORMS OF P53
    BARGONETTI, H
    CHEN, XB
    FARMER, G
    FRIEDLANDER, P
    JAYARAMAN, L
    MANFREDI, J
    MILLER, S
    WANG, Y
    PRIVES, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 207 - 207
  • [37] Down-Regulation of p53 Transactivation Domain Phosphorylation Against Reactive Oxygen Species Level is Associated with Poor Clinicopathological Features of Wild-Type p53 HCCs
    Kim, Hyeon Soap
    Jung, Guhung
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S45 - S45
  • [38] Requirement of wild-type p53 protein for maintenance of chromosomal integrity
    Honma, M
    Momose, M
    Tanabe, H
    Sakamoto, H
    Yu, YJ
    Little, JB
    Sofuni, T
    Hayashi, W
    MOLECULAR CARCINOGENESIS, 2000, 28 (04) : 203 - 214
  • [39] Prolonged wild-type p53 protein accumulation and cisplatin resistance
    Yazlovitskaya, EM
    DeHaan, RD
    Persons, DL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (04) : 732 - 737
  • [40] Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
    Peter Buttgereit
    Frank Schakowski
    Angela Märten
    Karsten Brand
    Sabine Renoth
    Carsten Ziske
    Björn Schöttker
    Oliver Ebert
    Roland Schroers
    Ingo GH Schmidt-Wolf
    Cancer Gene Therapy, 2001, 8 : 430 - 439